Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,001 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Completed

A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma

NCT01797523

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Sacred Heart Health Systems Pensacola, Florida, United States
  • MD Anderson Cooper Cancer Center Voorhees Township, New Jersey, United States
  • Memorial City Medical Center Houston, Texas, United States
  • Lyndon B Johnson General Hospital Houston, Texas, United States
View Trial Details
Completed

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

NCT03285152

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up) Commack, New York, United States
View Trial Details
Completed

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

NCT04463771

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +14 more
Locations
  • Alaska Womens Cancer Care Akwcc Anchorage, Alaska, United States
  • Honorhealth Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 65 locations
View Trial Details

Related conditions